Neurofibromatosis type 1 (NF1) is among the most common genetic disorders of humans and is caused by loss of neurofibromin, a large and highly conserved protein whose only known function is to serve as a GTPase-Activating Protein (GAP) for Ras. However, most Drosophila NF1 mutant phenotypes, including an overall growth deficiency, are not readily modified by manipulating Ras signaling strength, but are rescued by increasing signaling through the cAMP-dependent protein kinase A pathway. This has led to suggestions that NF1 has distinct Ras-and cAMP-related functions. Here we report that the Drosophila NF1 growth defect reflects a non-cell-autonomous requirement for NF1 in larval neurons that express the R-Ras ortholog Ras2, that NF1 is a GAP for Ras1 and Ras2, and that a functional NF1-GAP catalytic domain is both necessary and sufficient for rescue. Moreover, a Drosophila p120RasGAP ortholog, when expressed in the appropriate cells, can substitute for NF1 in growth regulation. Our results show that loss of NF1 can give rise to non-cell-autonomous developmental defects, implicate aberrant Ras-mediated signaling in larval neurons as the primary cause of the NF1 growth deficiency, and argue against the notion that neurofibromin has separable Ras-and cAMP-related functions.[Keywords: Neurofibromatosis type 1; organismal growth control; non-cell autonomy; Ras signal transduction;
Drosophila melanogaster]Supplemental material is available at http://www.genesdev.org. Neurofibromatosis type 1 (NF1, OMIM 162200) is a common genetic disorder, affecting two to three per 10,000 live births worldwide (Huson and Hughes 1994). NF1 patients are predisposed toward developing a variety of defects, the most characteristic of which include areas of abnormal skin pigmentation and benign tumors associated with peripheral nerves, termed neurofibromas. Less universal but more serious symptoms also include malignant peripheral nerve sheath tumors, other malignancies, and learning disabilities. Developmental abnormalities, such as specific skeletal defects, macrocephaly, and short stature, are also associated with NF1 (Huson and Hughes 1994). The >2800-amino-acid NF1 protein, termed neurofibromin, includes a segment related to the catalytic domains of Ras-specific GTPase-Activating Proteins (GAPs), and ample evidence supports the notion that the ability of neurofibromin to inactivate Ras plays a critical role in the development of NF1-associated tumors (Cichowski and Jacks 2001). The GAP-related domain (GRD) constitutes only ∼15% of neurofibromin, however, and it is less clear whether Ras signaling defects are also the immediate cause of other disease symptoms.A Drosophila melanogaster NF1 ortholog predicts a protein that is ∼60% identical to human neurofibromin over its entire length. We previously reported that Drosophila NF1-null mutants are viable, fertile, and normally patterned, but display a 15%-20% reduction in linear dimensions during all stages of post-embryonic